$MRNA is trading as it's not a Top RNA vaccine, market underestimates how huge the lead&amp;speed is. Noone can complete the study this fast, being #1 FDA approved has always been a huge advantage. Big doubts competitors can achieve on par or better $pfe $sny https://t.co/fGa9eg5I4i